|
1
|
Morris E and Roett MA: Genital cancers in
Women: Cervical cancer. FP Essent. 438:18–23. 2015.PubMed/NCBI
|
|
2
|
Arbyn M, Weiderpass E, Bruni L, de Sanjosé
S, Saraiya M, Ferlay J and Bray F: Estimates of incidence and
mortality of cervical cancer in 2018: A worldwide analysis. Lancet
Glob Health. 8:e191–e203. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kori M and Yalcin Arga K: Potential
biomarkers and therapeutic targets in cervical cancer: Insights
from the meta-analysis of transcriptomics data within network
biomedicine perspective. PLoS One. 13(e0200717)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Li H, Wu X and Cheng X: Advances in
diagnosis and treatment of metastatic cervical cancer. J Gynecol
Oncol. 27(e43)2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Yee GP, de Souza P and Khachigian LM:
Current and potential treatments for cervical cancer. Curr Cancer
Drug Targets. 13:205–220. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sanchez Calle A, Kawamura Y, Yamamoto Y,
Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in
cancer. Cancer Sci. 109:2093–2100. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Luan X and Wang Y: LncRNA XLOC_006390
facilitates cervical cancer tumorigenesis and metastasis as a ceRNA
against miR-331-3p and miR-338-3p. J Gynecol Oncol.
29(e95)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Liu Y, Yang Y, Li L, Liu Y, Geng P, Li G
and Song H: LncRNA SNHG1 enhances cell proliferation, migration,
and invasion in cervical cancer. Biochem Cell Biol. 96:38–43.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ye S, Sun B, Wu W, Yu C, Tian T, Lian Z,
Liang Q and Zhou Y: LINC01123 facilitates proliferation, invasion
and chemoresistance of colon cancer cells. Biosci Rep.
40(BSR20194062)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hua Q, Jin M, Mi B, Xu F, Li T, Zhao L,
Liu J and Huang G: LINC01123, a c-Myc-activated long non-coding
RNA, promotes proliferation and aerobic glycolysis of non-small
cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol.
12(91)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Juan C, Hua Q, Ruping Z and Tingting W:
miRNA-489 as a biomarker in diagnosis and treatment of cervical
cancer. Bratisl Lek Listy. 119:278–283. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yin XZ, Zhao DM, Zhang GX and Liu L:
Effect of miRNA-203 on cervical cancer cells and its underlying
mechanism. Genet Mol Res. 15:2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hua FF, Liu SS, Zhu LH, Wang YH, Liang X,
Ma N and Shi HR: MiRNA-338-3p regulates cervical cancer cells
proliferation by targeting MACC1 through MAPK signaling pathway.
Eur Rev Med Pharmacol Sci. 21:5342–5352. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liu S, Song L, Yao H, Zhang L, Xu D, Li Q
and Li Y: Preserved miR-361-3p Expression is an independent
prognostic indicator of favorable survival in cervical cancer. Dis
Markers. 2018(8949606)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang J, Li H and Liang Z: circ-MYBL2
serves as a sponge for miR-361-3p promoting cervical cancer cells
proliferation and invasion. Onco Targets Ther. 12:9957–9964.
2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Matsuo K, Machida H, Mandelbaum RS,
Konishi I and Mikami M: Validation of the 2018 FIGO cervical cancer
staging system. Gynecol Oncol. 152:97–93. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tewari KS, Sill MW, Long HJ III, Penson
RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao
MM, et al: Improved survival with bevacizumab in advanced cervical
cancer. N Engl J Med. 370:734–743. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hsu W, Liu L, Chen X, Zhang Y and Zhu W:
LncRNA CASC11 promotes the cervical cancer progression by
activating Wnt/beta-catenin signaling pathway. Biol Res.
52(33)2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang R, Li Y, Du P, Zhang X, Li X and
Cheng G: Hypomethylation of the lncRNA SOX21-AS1 has clinical
prognostic value in cervical cancer. Life Sci.
233(116708)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang P, Long Q, Zeng S, Wen M and Lu Q:
FOXC1-induced LINC01123 acts as a mediator in triple negative
breast cancer. Cancer Cell Int. 20(199)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yang Y, Wu J, Zhou H, Liu W, Wang J and
Zhang Q: STAT1-induced upregulation of lncRNA LINC01123 predicts
poor prognosis and promotes the progression of endometrial cancer
through miR-516b/KIF4A. Cell Cycle. 19:1502–1516. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu J, Zhu J, Xiao Z, Wang X and Luo J:
BBOX1-AS1 contributes to colorectal cancer progression by sponging
hsa-miR-361-3p and targeting SH2B1. FEBS Open Bio, Jan 27, 2020
(Epub ahead of print).
|
|
25
|
Xia F, Chen Y, Jiang B, Bai N and Li X:
Hsa_circ_0011385 accelerates the progression of thyroid cancer by
targeting miR-361-3p. Cancer Cell Int. 20(49)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Shang T, Zhou X and Chen W: LINC01123
promotes progression of colorectal cancer via miR-625-5p/LASP1
axis. Cancer Biother Radiopharm, May 18, 2020 (Epub ahead of
print).
|
|
28
|
Li F, Zhu W and Wang Z: Long noncoding RNA
LINC00460 promotes the progression of cervical cancer via
regulation of the miR-361-3p/Gli1 axis. Hum Cell. 34:229–237.
2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Chen W, Wang J, Liu S, Wang S, Cheng Y,
Zhou W, Duan C and Zhang C: MicroRNA-361-3p suppresses tumor cell
proliferation and metastasis by directly targeting SH2B1 in NSCLC.
J Exp Clin Cancer Res. 35(76)2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Huang S, Yuan S, Dong M, Su J, Yu C, Shen
Y, Xie X, Yu Y, Yu X, Chen S, et al: The phylogenetic analysis of
tetraspanins projects the evolution of cell-cell interactions from
unicellular to multicellular organisms. Genomics. 86:674–684.
2005.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Duan J, Liu J, Liu Y, Huang B and Rao L:
miR-491-3p suppresses the growth and invasion of osteosarcoma cells
by targeting TSPAN1. Mol Med Rep. 16:5568–5574. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang S, Liu X, Khan AA, Li H, Tahir M, Yan
X, Wang J and Huang H: miR-216a-mediated upregulation of TSPAN1
contributes to pancreatic cancer progression via transcriptional
regulation of ITGA2. Am J Cancer Res. 10:1115–1129. 2020.PubMed/NCBI
|
|
33
|
Chen L, Li X, Wang GL, Wang Y, Zhu YY and
Zhu J: Clinicopathological significance of overexpression of
TSPAN1, Ki67 and CD34 in gastric carcinoma. Tumori. 94:531–538.
2008.PubMed/NCBI
|
|
34
|
Scholz CJ, Kurzeder C, Koretz K, Windisch
J, Kreienberg R, Sauer G and Deissler H: Tspan-1 is a tetraspanin
preferentially expressed by mucinous and endometrioid subtypes of
human ovarian carcinomas. Cancer Lett. 275:198–203. 2009.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Tian J, Zhang R, Piao H, Li X, Sheng W,
Zhou J, Dong M, Zhang X, Yan X, Shang W, et al: Silencing Tspan1
inhibits migration and invasion, and induces the apoptosis of human
pancreatic cancer cells. Mol Med Rep. 18:3280–3288. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Hölters S, Anacker J, Jansen L,
Beer-Grondke K, Dürst M and Rubio I: Tetraspanin 1 promotes
invasiveness of cervical cancer cells. Int J Oncol. 43:503–512.
2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lu Z, Luo T, Nie M, Pang T, Zhang X, Shen
X, Ma L, Bi J, Wei G, Fang G and Xue X: TSPAN1 functions as an
oncogene in gastric cancer and is downregulated by miR-573. FEBS
Lett. 589:1988–1994. 2015.PubMed/NCBI View Article : Google Scholar
|
